Impact of COVID-19 on HV trials [Study Per­for­mance]

posted by drgunasakaran1  – 2021-06-03 06:06 (116 d 00:38 ago) – Posting: # 22389
Views: 476

Dear Ms Silvia Giarcovich,

» (always with a nurse at all times and a medical doctor visiting all the volunteers, etc etc)?

It is highly advisable to keep the volunteers under the medical supervision of physicians for a specified period after administration of investigational product. Also, in case of any emergency, housing the subjects in their home is not practically safe to manage any serious adverse events.

» One possibility would be to include a PCR / COVID-19 test both at screening and before each administration period and at the end of the study.

Yes. We can include negative RT-PCR as one of the subject's inclusion criteria during screening/each check-in/post study evaluation in the protocol itself to minimize the risk of infection/transmission of Coronavirus during the housing period.

Dr S Gunasakaran MBBS MD
Disclaimer: The replies/posts are my personal opinions and it does not represent my company views on the same.

Complete thread:

Activity
 Admin contact
21,700 posts in 4,538 threads, 1,542 registered users;
online 2 (0 registered, 2 guests [including 2 identified bots]).
Forum time: Monday 06:45 CEST (Europe/Vienna)

In the beginner’s mind there are many possibilities.
In the expert’s mind there are few.    Shunryu Suzuki

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5